GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (NAS:NVAX) » Definitions » E10

NVAX (Novavax) E10 : $-12.57 (As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is Novavax E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novavax's adjusted earnings per share data for the three months ended in Mar. 2025 was $2.930. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-12.57 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average E10 Growth Rate was -2.10% per year. During the past 5 years, the average E10 Growth Rate was -7.80% per year. During the past 10 years, the average E10 Growth Rate was -5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novavax was 11.20% per year. The lowest was -12.00% per year. And the median was -2.10% per year.

As of today (2025-07-13), Novavax's current stock price is $6.84. Novavax's E10 for the quarter that ended in Mar. 2025 was $-12.57. Novavax's Shiller PE Ratio of today is .


Novavax E10 Historical Data

The historical data trend for Novavax's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax E10 Chart

Novavax Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.55 -12.16 -13.21 -13.40 -12.96

Novavax Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.57 -13.34 -13.25 -12.96 -12.57

Competitive Comparison of Novavax's E10

For the Biotechnology subindustry, Novavax's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novavax's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novavax's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novavax's Shiller PE Ratio falls into.


;
;

Novavax E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novavax's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.93/134.9266*134.9266
=2.930

Current CPI (Mar. 2025) = 134.9266.

Novavax Quarterly Data

per share eps CPI Adj_EPS
201506 -1.600 100.684 -2.144
201509 -2.400 100.392 -3.226
201512 -5.800 99.792 -7.842
201603 -5.800 100.470 -7.789
201606 -5.800 101.688 -7.696
201609 -4.800 101.861 -6.358
201612 -4.200 101.863 -5.563
201703 -3.200 102.862 -4.198
201706 -3.200 103.349 -4.178
201709 -3.010 104.136 -3.900
201712 -3.200 104.011 -4.151
201803 -2.800 105.290 -3.588
201806 -2.370 106.317 -3.008
201809 -2.330 106.507 -2.952
201812 -2.600 105.998 -3.310
201903 -2.110 107.251 -2.654
201906 -1.690 108.070 -2.110
201909 -0.740 108.329 -0.922
201912 -1.130 108.420 -1.406
202003 -0.580 108.902 -0.719
202006 -0.300 108.767 -0.372
202009 -3.210 109.815 -3.944
202012 -2.700 109.897 -3.315
202103 -3.050 111.754 -3.682
202106 -4.750 114.631 -5.591
202109 -4.310 115.734 -5.025
202112 -11.180 117.630 -12.824
202203 2.560 121.301 2.848
202206 -6.530 125.017 -7.048
202209 -2.150 125.227 -2.317
202212 -2.280 125.222 -2.457
202303 -3.410 127.348 -3.613
202306 0.580 128.729 0.608
202309 -1.260 129.860 -1.309
202312 -1.470 129.419 -1.533
202403 -1.050 131.776 -1.075
202406 0.990 132.554 1.008
202409 -0.760 133.029 -0.771
202412 -0.510 133.157 -0.517
202503 2.930 134.927 2.930

Add all the adjusted EPS together and divide 10 will get our e10.


Novavax  (NAS:NVAX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novavax E10 Related Terms

Thank you for viewing the detailed overview of Novavax's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Novavax Business Description

Address
700 Quince Orchard Road, Gaithersburg, MD, USA, 20878
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
Executives
James F Young director ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878
Rachel K. King director C/O GLYCOMIMETICS, INC., 401 PROFESSIONAL DRIVE, SUITE 250, GAITHERSBURG MD 20879
Filip Dubovsky officer: President, R&D C/O NOVAVAX INC., 21 FIRSTFIELD ROAD, GAITHERSBURG MD 20878
Gregory M Glenn officer: President, R&D 20 FIRSTFIELD ROAD, #250, GAITHERSBURG MD 20878
Elaine O'hara officer: EVP, Chief Strategy Officer 333 NORTH WARREN AVENUE, MALVERN PA 19355
John C Jacobs director, officer: President and CEO 630 W. GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING PA 19462
Richard J Rodgers director C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Herrmann John A Iii officer: SVP, General Counsel C/O NOVAVAX, INC., 20 FIRSTFIELD ROAD, GAITHERSBURG MD 20878
Stanley C Erck director, officer: President and CEO 20 FIRSTFIELD ROAD, #250, GAITHERSBURG MD 20878
John Trizzino officer: SVP, CBO and CFO 9920 BELWARD CAMPUS DRIVE, ROCKVILLE MD 20850
David M Mott director 1119 ST. PAUL STREET, BALTIMORE MD 21202
James Patrick Kelly officer: EVP, CFO and Treasurer C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE, ROCKVILLE MD 20850
Gary C Evans director 1048 TEXAN TRAIL, GRAPEVINE TX 76051
Mcmanus Michael A Jr director 241-02 NORTHERN BLVD, DOUGLASTON NY 11362
Margaret G Mcglynn director C/O MERCK & CO INC, ONE MERCK DRIVE PO BOX 100, WHITEHOUSE STATION NJ 08889-0100